TY - JOUR
T1 - Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers
AU - Laing, Eric D.
AU - Weiss, Carol D.
AU - Samuels, Emily C.
AU - Coggins, Si'Ana A.
AU - Wang, Wei
AU - Wang, Richard
AU - Vassell, Russell
AU - Sterling, Spencer L.
AU - Tso, Marana S.
AU - Conner, Tonia
AU - Goguet, Emilie
AU - Moser, Matthew
AU - Jackson-Thompson, Belinda M.
AU - Illinik, Luca
AU - Davies, Julian
AU - Ortega, Orlando
AU - Parmelee, Edward
AU - Hollis-Perry, Monique
AU - Maiolatesi, Santina E.
AU - Wang, Gregory
AU - Ramsey, Kathleen F.
AU - Reyes, Anatalio E.
AU - Alcorta, Yolanda
AU - Wong, Mimi A.
AU - Lindrose, Alyssa R.
AU - Duplessis, Christopher A.
AU - Tribble, David R.
AU - Malloy, Allison M.W.
AU - Burgess, Timothy H.
AU - Pollett, Simon D.
AU - Olsen, Cara H.
AU - Broder, Christopher C.
AU - Mitre, Edward
N1 - Publisher Copyright:
© 2022 Centers for Disease Control and Prevention (CDC). All rights reserved.
PY - 2022/4
Y1 - 2022/4
N2 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies decay but persist 6 months postvaccination; lower levels of neutralizing titers persist against Delta than wild-type virus. Of 227 vaccinated healthcare workers tested, only 2 experienced outpatient symptomatic breakthrough infections, despite 59/227 exhibiting serologic evidence of SARS-CoV-2 infection, defined as presence of nucleocapsid protein antibodies.
AB - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies decay but persist 6 months postvaccination; lower levels of neutralizing titers persist against Delta than wild-type virus. Of 227 vaccinated healthcare workers tested, only 2 experienced outpatient symptomatic breakthrough infections, despite 59/227 exhibiting serologic evidence of SARS-CoV-2 infection, defined as presence of nucleocapsid protein antibodies.
UR - http://www.scopus.com/inward/record.url?scp=85127183262&partnerID=8YFLogxK
U2 - 10.3201/eid2804.212037
DO - 10.3201/eid2804.212037
M3 - Article
C2 - 35203111
AN - SCOPUS:85127183262
SN - 1080-6040
VL - 28
SP - 828
EP - 832
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 4
ER -